Vascular surgery leader discusses advances, awareness and AI in care
Posted:
Dr. Matthew Eagleton, President of the Society for Vascular Surgery and chief of vascular and endovascular surgery at Massachusetts General Hospital, joined Fierce Healthcare to discuss the evolving landscape of vascular care and why public awareness is more critical than ever.
Read more here.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us